Vera concludes Phase IIb IgA nephropathy trial subject enrolment
The variation in proteinuria as analysed by UPCR at weeks 24 and 36, respectively, are the primary and secondary endpoints.
Genito Urinary System And Sex Hormones
Latest in
Genito Urinary System And Sex Hormones
Urovant reports positive data from Phase IIa OAB therapy trial
In the trial, single doses of URO-902 demonstrated to be well tolerated versus placebo.
Major unmet needs in overactive bladder unlikely to be addressed in the near future
GlobalData expects there will still be a considerable level of unmet need remaining in the overactive bladder segment by 2030.
By
Regulatory roundup: Editas’ CRISPR asset make strides after positive eye disease trial
MacroGenics in multiple cancers and Merck’s Bavencio are among other assets reviewed by GlobalData’s Investigative News team.
By
Semaine: building an evidence base in women’s health
Natural health firm Semaine discusses its new approach to period pain and what it’s like to run trials as a…
By
Poor adherence to overactive bladder medication signifies need for novel drugs
New research into urinary incontinence could aid the development of targeted treatment methods for overactive bladder and other similar conditions.
By
September’s top news stories
NIH kick starts hunt for neuroprotective stroke treatments and Denali begins dosing Parkinson’s patients in Phase Ib trial. Clinicaltrialsarena.com wraps…